ArticleScientific reports2025
The circRNA circKNSTRN promotes breast cancer progression by modulating the miR-320a-3p/SPAG5 axis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Breast cancer (BC) ranks as the most prevalent cancer and the primary cause of cancer-related mortality among women globally. Our previous research has proved that Sperm-associated antigen 5 (SPAG5) is a potential prognostic biomarker in BC. However, the possible biological function and molecular mechanism of SPAG5 in BC remain unknown. Next, we identified a circular RNA, circKNSTRN (hsa_circ_0103433), upstream of SPAG5, which may synergize with SPAG5 to impact BC. In this study, we aimed to explore the association between circKNSTRN and SPAG5 and their roles, especially the function of circKNSTRN in BC. The existence of circKNSTRN was confirmed by the Sanger sequence and RT-PCR. High expression level of circKNSTRN was tested in human BC cell lines and tissues by RT-qPCR. Functionally, the overexpression of circKNSTRN facilitated the proliferation and migration of BC cells, while also regulating cell apoptosis and cell cycle. Conversely, the knockdown of circKNSTRN yielded the opposite results. Mechanistically, miR-320a-3p was shown to bind to circKNSTRN and inhibit the proliferation and migration abilities of BC cells through bioinformatic analysis, dual-luciferase reporter assays, RNA pull-down experiments, and FISH assays. The inhibition of miR-320a-3p reverses the effect. Moreover, circKNSTRN regulated the expression level of SPAG5 by sponging miR-320a-3p. Significance: circKNSTRN was first identified and proved to promote the progression of BC through the miR-320a-3p/SPAG5 axis. The circKNSTRN/miR-320a-3p/SPAG5 axis may serve as a promising therapeutic and prognostic target for BC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.